Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Regulatory tracker: Enhertu picks up priority review in new use
Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Fraiser Kansteiner
,
Zoey Becker
,
Angus Liu
,
Kevin Dunleavy
,
Eric Sagonowsky
Sep 24, 2025 8:45am
Rising Stars: Madison Norman on the power of human connection
Sep 24, 2025 6:00am
Gen Z shows least trust, satisfaction in pharma: survey
Sep 23, 2025 2:45pm
J&J subsidiary slapped with FDA warning letter
Sep 23, 2025 2:22pm
Lilly reveals plans for $6.5B API production facility in Texas
Sep 23, 2025 1:00pm
Sobi tops Roche in rare disease patients' reputation rankings
Sep 23, 2025 12:33pm
More News
Moderna says updated mNEXSPIKE induces strong immune response
Sep 23, 2025 10:15am
Korea's Celltrion throws down $330M for Lilly plant in N.J.
Sep 23, 2025 9:24am
Issues at Novo site delay Scholar Rock's bid for SMA approval
Sep 23, 2025 9:19am
FDA urges doctors to minimize Tylenol use during pregnancy
Sep 23, 2025 8:55am